How to Use Strategic Mapping to Interpret and Optimize Market Intelligence
~ featuring ~
Lisa Giles is President & CEO
at Giles & Associates Consultancy
Arik Johnson is Chairman &
Founder at Aurora WDC
Carl Derenfeld is Director of Integrative Intelligence at Aurora WDC
From leading or facilitating 100s of strategic projects over the past 25 years, we saw the need for a better approach to capturing interpreting and utilizing the masses of research and intelligence we gather in which to envision the future and construct strategic plans. GACs experience also shows that the need for intelligence and the dissemination of the findings, is becoming less targeted to any one functional group and is evolving to provide benefits for diverse members of cross-functional teams. To address this need we developed a methodology and software application to improve digestion, sharing and refreshing of information. Our StratMap approach can benefit teams and organizations in not only compiling intelligence but envisioning how it will likely impact the market place, your competitors and you. Providing an integrative cross-functional approach can raise the appreciation for the role of intelligence to optimize strategy and for the intelligence team’s position as the catalyst within the organization.
- Share the strategic framework that can be manual or software enabled
- Discuss the information mapping method and rationale
- Share a few examples of how it has been utilized
- Brainstorm with the audience for how it could be meaningfully applied to the scope of your intelligence practices
- Describe how the method and tool has been advanced to help create and keep alive strategic plans
About the Provocateur
Ms. Giles is the President and CEO of Giles & Associates Consultancy (GAC), a private strategy consulting firm. For over 15 years, GAC has provided strategic consulting services for portfolio optimization, global product launch, market landscape and research across large, specialty and orphan diseases.
The firm’s extensive list of clients spans across the Life Science Industry from Pharmaceutical, Diagnostic, Device, Government Agencies, to Academic Research Institutions. The firm’s expert teams work primarily with those discovering and advancing innovative products. GAC advises corporate boards, CEOs, and executive leadership teams on strategic direction, pipeline optimization, and market entry strategies.
In 2013, she also founded and is also the CEO of Optivara, Inc., a software-as-a-service (SaaS) company that offers a suite of enabling tools to life sciences and innovative companies.
Prior to GAC, Ms. Giles was Vice President of Strategy Development, at G.D. Searle & Company, where she oversaw global pharmaceutical strategic planning, portfolio decision analysis, marketing research, portfolio optimization, and transaction analysis. Prior to Searle, she was a partner in Business Strategy Consultants, Portland Oregon, and a Director of Strategic Planning and Marketing for Abbott Laboratories.
Ms. Giles currently serves on the board of directors for GenMark Diagnostics, Inc. since March 2015, and Northwestern Memorial Foundation Board since 2013. She previously served as a member of the board of directors of Durata Therapeutics, Inc., from August 2012 until its acquisition by Actavis plc in November 2014. Ms. Giles received a B.S. from Juniata College and has completed Executive Management Programs at both Stanford and the University of Chicago.
She was recently recognized by PharmaVoice as one of the 2015 Pharma100 “Most Inspiring People in the Life Sciences Industry”. In 2010 she was awarded “Enterprising Women of the Year”.
We hope you can join us.
Register for this Webinar